Piper Sandler & Co. reported 1 positions worth $253.77K for the quarter ended Mar 31, 2026, up 76.2% on the prior quarter. It opened 0 new positions, added to 0, trimmed 0 and exited 0. Its largest holding is Shattuck Labs, Inc. at 100% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
No positions were added to this quarter.
No positions were reduced this quarter.
No new positions this quarter.
No positions were closed this quarter.
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | STTK Shattuck Labs, Inc. | Healthcare | 39.5K | $253.77K | 100% | 0 | 0.0% | Unchanged | 0.04% |
Tip. Select a row to see that position’s full history at Piper Sandler.
As of its Q1 2026 13F filing, Piper Sandler & Co.’s five largest positions were Shattuck Labs, Inc. (STTK) at 100.0% of the reported portfolio.
Piper Sandler & Co. reported a 13F portfolio worth $253.77K across 1 positions for Q1 2026. That is up 76.2% from the previous quarter.
From the Form 13F-HR reports Piper Sandler & Co. files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.